---
title: "enGene Therapeutics' Ryan Daws to Depart; Kathleen Richton Named SVP, Finance"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/289791527.md"
description: "enGene Therapeutics' Ryan Daws to Depart; Kathleen Richton Named SVP, Finance"
datetime: "2026-06-15T13:23:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/289791527.md)
  - [en](https://longbridge.com/en/news/289791527.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/289791527.md)
generator: "portal-rs"
---

# enGene Therapeutics' Ryan Daws to Depart; Kathleen Richton Named SVP, Finance

**enGene Therapeutics announced that CFO Ryan Daws will depart effective July 15, 2026, and Kathleen Richton was appointed Senior Vice President, Finance and will become principal financial officer and principal accounting officer effective on or about July 16, 2026.**

Individual

Ryan Daws

Kathleen Richton

Role

Chief Financial Officer

Senior Vice President, Finance; Principal Financial Officer; Principal Accounting Officer

Type of Change

Departure

Appointment

Effective Date

July 15, 2026

On or about July 16, 2026

Reason

Strategic restructuring

Board appointment in connection with restructuring

Replacement Info

To be succeeded by Kathleen Richton as principal financial and accounting officer

N/A

Background Details

Expected separation agreement may provide salary continuation, health benefit payments, prorated 2026 bonus, and vesting of certain equity awards (per filing)

Served as VP, Controller since Mar 2026; Exec Director of Finance Jan 2025–Mar 2026; prior roles at Sumitomo Pharma America and Sunovion; B.Sc. and M.S. from Bentley; CPA in Massachusetts

Board/Committee Role Changes

Not disclosed

Not disclosed

Original SEC Filing: enGene Therapeutics Inc. \[ ENGN \] - 8-K - Jun. 15, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [ENGN.US](https://longbridge.com/en/quote/ENGN.US.md)
- [4506.JP](https://longbridge.com/en/quote/4506.JP.md)
- [ENGNW.US](https://longbridge.com/en/quote/ENGNW.US.md)

## Related News & Research

- [enGene Therapeutics to Present at Wells Fargo Healthcare Conference](https://longbridge.com/en/news/297652876.md)
- [PETROBRAS updates financial events calendar for 2026](https://longbridge.com/en/news/298078546.md)
- [Eternit updates financial events calendar for 2026](https://longbridge.com/en/news/297909021.md)
- [PulteGroup declares Q3 2026 dividend of R$ 0.9 per unit](https://longbridge.com/en/news/297931957.md)
- [Marisa updates financial events calendar for 2026](https://longbridge.com/en/news/297913424.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**